Maltese Laboratories incurred the following research and development costs related to its pharmaceutical business:

Internal projects $($salaries$,$ supplies, overhead for R&D facilities$)$ $ $649,000$

Payment to acquire R&D from a third party related to a specific project $77,900$

Costs of an R&D project to be sold under contract to Libo Pharmacy, a third party $84,900$

In$-$process R&D associated with the acquisition of Curatics, an independent research company. $153,800$

What amount should Maltese report as research and development expense in its income statement?